Dr. LIU Nan graduated from Jilin University with a master’s degree in 2014 and pursued a doctoral degree at Zhejiang University School of Medicine in 2022. She mainly engages in comprehensive treatments such as chemotherapy, targeted therapy, and immunotherapy for digestive tract tumors affecting the liver, biliary tract, and pancreas. She focuses on clinical research on new anti-tumor drugs and clinical and translational research on digestive tract tumors.

 She has published dozens of professional papers, including one SCI paper published in a TOP journal. She participated in the “Pioneer” and “Leading Goose” R&D Program of Zhejiang and multiple international as well as domestic prospective multicenter clinical studies.